| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.044 | 0.8 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |